[1]
“Clinical Analysis of Apatinib in the Treatment of Patients with Residual Tumor after Radical Chemoradiotherapy for Locally Advanced Cervical Cancer ”, J. Can. Res. Updates, vol. 9, no. 1, pp. 20–24, Sep. 2020, doi: 10.30683/1929-2279.2020.09.04.